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Background: Mycoprotein is a fungal-derived sustainable protein-rich food source, and its 2 
ingestion results in systemic amino acid and leucine concentrations similar to that following 3 
milk protein ingestion.  4 
Objective: We assessed the mixed skeletal muscle protein synthetic response to the ingestion 5 
of a single bolus of mycoprotein compared with a leucine matched bolus of milk protein, in 6 
rested and exercised muscle of resistance-trained young men.  7 
Design: Twenty resistance-trained healthy young males (age: 22±1 y, body mass: 82±2 kg, 8 
BMI: 25±1 kg·m-2) took part in a randomized, double-blind, parallel-group study. Participants 9 
received primed, continuous infusions of L-[ring-2H5]phenylalanine and ingested either 31 g 10 
(26.2 g protein: 2.5 g leucine) milk protein (MILK) or 70 g (31.5 g protein: 2.5 g leucine) 11 
mycoprotein (MYCO) following a bout of unilateral resistance-type exercise (contralateral 12 
leg acting as resting control). Blood and m. vastus lateralis muscle samples were collected 13 
before exercise and protein ingestion, and following a 4 h postprandial period to assess mixed 14 
muscle fractional protein synthetic rates (FSR) and myocellular signalling in response to the 15 
protein beverages in resting and exercised muscle.  16 
Results: Mixed muscle FSR increased following MILK ingestion (from 0.036±0.008 to 17 
0.052±0.006%·h-1 in rested, and 0.035±0.008 to 0.056±0.005%·h-1 in exercised muscle; 18 
P<0.01) but to a greater extent following MYCO ingestion (from 0.025±0.006 to 19 
0.057±0.004%·h-1 in rested, and 0.024±0.007 to 0.072±0.005%·h-1 in exercised muscle; 20 
P<0.0001) (treatment × time interaction effect; P<0.05). Postprandial FSRs trended to be 21 
greater in MYCO compared with MILK (0.065±0.004 vs 0.054±0.004%·h-1, respectively; 22 
P=0.093) and the postprandial rise in FSR was greater in MYCO compared with MILK (Δ 23 
0.040±0.006 vs Δ 0.018±0.005%·h-1, respectively; P<0.01). 24 
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Conclusions: The ingestion of a single bolus of mycoprotein stimulates resting and post-25 
exercise muscle protein synthesis rates, and to a greater extent compared with a leucine 26 





Adequate dietary protein intake is required to maintain skeletal muscle mass and to facilitate 30 
the remodelling and/or hypertrophy of muscle tissue in response to exercise training. 31 
Mechanistically, this is largely achieved by dietary protein ingestion transiently (2-5 h) 32 
stimulating muscle protein synthesis rates (1-3), primarily due to a postprandial elevation of 33 
plasma essential amino acid concentrations (4), particularly leucine (5, 6). A single bout of 34 
resistance exercise also stimulates muscle protein synthesis rates for up to (and at least) 48 h 35 
(7, 8), whilst sensitising muscle tissue to the anabolic effects of dietary protein for at least 24 36 
h (7, 8). Consequently, research has sought to identify aspects of protein nutrition (e.g. 37 
amount and timing) that can be manipulated to optimally support post-exercise muscle 38 
protein synthesis rates (1, 3, 9-12). However, information relating to the anabolic properties 39 
of non-animal derived dietary protein sources is lacking, which is concerning given the 40 
increasing emphasis on dietary sustainability.  41 
Animal-derived dietary protein sources, such as whey (1, 2, 11, 13, 14), casein (13, 15), milk 42 
(16, 17) beef (17-20) and egg (3, 21) have all been shown to stimulate post-exercise muscle 43 
protein synthesis rates. It is assumed that plant-based dietary protein sources are inferior in 44 
their capacity to stimulate muscle protein synthesis rates, due to their typically slower 45 
digestibility, lower bioavailability, and lower essential amino acid and leucine content (22). 46 
Indeed, whey protein stimulates muscle protein synthesis rates to a greater extent than soy in 47 
young men (1, 14) and, compared to wheat protein in older men (13). To date, however, these 48 
are the only non-animal derived protein sources to be studied with respect to their impact on 49 
muscle protein synthesis.  50 
Mycoprotein is a sustainably produced food source rich in protein (~45% of total mass) and 51 
essential amino acids (~44% of total protein) derived from the cultivation of the fungus 52 
Fusarium venenatum. We have reported that total postprandial essential amino acid (and 53 
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leucine) concentrations following mycoprotein ingestion are comparable to that seen 54 
following milk protein ingestion (23), a finding atypical of animal versus non-animal dietary 55 
protein comparisons (13, 24). Further, essential amino acid concentrations following 56 
mycoprotein ingestion increased in a dose-response fashion up to 60-80 g mycoprotein 57 
consumption (27-36 g protein, 2.1-2.9 g leucine) (23), suggesting mycoprotein would be 58 
capable of robustly stimulating muscle protein synthesis rates. 59 
In the present work, we tested the hypothesis that the ingestion of a 70 g bolus of 60 
mycoprotein (31.5 g protein, 2.5 g leucine) would stimulate mixed muscle protein synthesis 61 
rates over a four h postprandial period in both rested and exercised skeletal muscle of 62 
resistance-trained, healthy young men. We compared the muscle protein synthetic response 63 
of mycoprotein ingestion to a leucine-matched bolus of milk protein. Here, we hypothesised 64 
that, despite equivalent leucine contents, due to slower aminoacidemia (23), muscle protein 65 
synthesis rates would increase to a lesser extent following mycoprotein ingestion. We chose 66 
to match the two beverages on leucine content as various lines of enquiry suggest leucine 67 
content, rather than total protein, is the primary factor determining the postprandial muscle 68 






Twenty young, healthy (age: 22±1 y, body mass: 82±2 kg, BMI: 25±1 kg·m-2) men 73 
volunteered to take part in the present study (Supplementary Figure 1). Participants’ 74 
characteristics are displayed in Table 1. Participants were recreationally active and 75 
experienced with resistance training (at least 3 times per week for at least 3 months prior to 76 
participation). Participants were deemed healthy based on their blood pressure 77 
(≤140/90mmHg), BMI (18-30 kg·m-2) and responses to a routine medical screening 78 
questionnaire (absence of any diagnosed metabolic impairment, cardiovascular disease, or 79 
motor disorders), and were informed of the experimental procedures, potential risks, and the 80 
purpose of the study prior to providing full written consent. Participants were all ‘tracer 81 
naïve’ having not undergone any previous stable isotope amino acid infusion protocols. The 82 
study was approved by the Sport and Health Sciences ethics committee of the University of 83 
Exeter (REF NO. 161026/B/05) in accordance with standards for human research as outlined 84 
in the declaration of Helsinki. Recruitment and data collection were completed between 85 
January 2017 and August 2017 at The University of Exeter. 86 
 87 
Pre-testing 88 
Following screening and acceptance onto the study, all participants underwent a single pre-89 
testing session, which took place at least 5 days prior to the experimental trial. Participants 90 
were familiarised with the exercise equipment and exercise protocol, and body fat and lean 91 
mass were determined by Air Displacement Plethysmography (BodPod, Life Measurement, 92 
Inc. Concord, CA, USA). Participants were familiarised with the unilateral resistance-type 93 
exercise that was employed in the experimental protocol. This consisted of 5 sets of 30 94 
repetitions of maximal concentric isokinetic leg extension and leg flexion contractions on a 95 
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Biodex System 3 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, USA) at a 96 
speed of 60° per second over a central 80° range of motion using their self-reported dominant 97 
leg. Verbal encouragement was provided throughout the familiarisation and experimental 98 
testing to engender maximal effort through every repetition. Work done (J) was recorded for 99 
each completed set, and fatigue was calculated as the percentage decrement in work done 100 
between the first and last set. Participants were instructed to report their habitual dietary 101 
intake by recording a weighted food diary for two weekdays, and one weekend day prior to 102 
partaking in the study (Table 1) (Nutritics LTD, Dublin, Ireland). 103 
 104 
Experimental protocol 105 
Participants were randomly assigned to two parallel-groups, A or B, by the lead investigator 106 
and completed a single trial in a double-blind fashion. An overview of the experimental 107 
protocol is shown in Figure 1. Participants were directed to abstain from vigorous physical 108 
activity and alcohol consumption in the 48 h preceding the trial. All participants were 109 
provided with and consumed a standardised meal ~10.5 h prior to the start of the 110 
experimental trial (744 kcal [3.1 MJ], 29% energy (%En) fat, 20%En protein, 51%En 111 
carbohydrate). On the day of the trial, participants arrived at the laboratory between 07:00 - 112 
08:00 after a 10 h overnight fast. A TeflonTM cannula was inserted into an antecubital vein of 113 
one arm in preparation for stable isotope infusion, a baseline venous blood sample was taken 114 
from this site to measure background isotope enrichments prior to infusion. Following 115 
baseline blood sampling (t = -210 min) the phenylalanine and tyrosine pools were primed 116 
with a single intravenous dose of L-[ring-2H5]phenylalanine (2.12 µmol/kg) and L-[3,3-117 
2H2]tyrosine (0.75 µmol/kg). Thereafter, continuous tracer infusion was initiated and 118 
maintained at a rate of 0.035 µmol·kg-1·min-1 for L-[ring-2H5]phenylalanine and 0.012 119 
µmol·kg-1·min-1 for L-[3,3-2H2]tyrosine for the duration of the protocol. Once the infusion 120 
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had begun, a second Teflon cannula was inserted into a dorsal hand vein of the contralateral 121 
arm and placed in a warmed air hand unit (55°C) for arterialized venous blood sampling (27). 122 
Arterialized venous blood samples were collected throughout the experimental protocol at the 123 
following time points: t = -180, -120, -60, 0 (drink consumption), 15, 30, 45, 60, 75, 90, 120, 124 
150, 180, 210 and 240 min. A baseline muscle sample was collected after 90 min of the 125 
infusion (t -120 min) from the non-dominant leg (designated as the ‘resting leg’). Muscle 126 
biopsies were collected from the mid-region of the m. vastus lateralis (approx. 15 cm above 127 
the patella) with a modified Bergström suction needle under local anaesthesia (2% lidocaine). 128 
All biopsy samples were immediately freed from any visible blood, adipose and connective 129 
tissue, frozen in liquid nitrogen (within 30 s), and stored at –80°C until subsequent analysis. 130 
Eighty-five min after the initial biopsy (t = -35 min), participants undertook the unilateral 131 
resistance-type exercise protocol, as previously described, which took 30 min. Immediately 132 
following exercise bilateral muscle biopsies were collected (i.e. from both the rested and 133 
exercised leg). Immediately post-biopsy (t = 0 min) participants consumed either a milk 134 
protein (MILK) or mycoprotein (MYCO) beverage, within an allotted 5 min period, with the 135 
experimental drinks administered in a double-blind manner. Thereafter, participants rested in 136 
a semi-supine position for 4 h, after which further bilateral biopsies were collected 1–2 cm 137 
proximal to the previous incisions (t = 240 min).  138 
 139 
Experimental beverage preparations 140 
Freeze-dried isolated milk protein concentrate was obtained from a commercial supplier 141 
(Bulk Powders, Colchester, UK) and freeze-dried mycoprotein was produced by and obtained 142 
from Marlow Foods Ltd, Quorn Foods, Stokesley, UK. Both protein sources were 143 
independently analysed by a third party company for energy, macronutrient content and 144 
amino acid composition (Premier Analytical Services, High Wycombe, UK). The powdered 145 
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protein sources were prepared the evening before the experimental trial. The protein sources 146 
were assimilated with 400 mL water and 10 g of artificial energy-free flavouring (Myprotein, 147 
Manchester, UK), blended for approximately 2 min, topped up with water to make a total 148 
final beverage volume of 600 mL and refrigerated overnight. Drinks were enriched (2.5%) 149 
with L-[ring-2H5]phenylalanine to account for postprandial tracer dilution by non-labelled 150 
phenylalanine and to maintain a systemic isotopic steady-state following protein ingestion (1, 151 
3). Following drink consumption by the participant, an additional 50 mL of water was then 152 
added to ‘wash’ the bottle and ensure that all protein had been consumed, making a total 153 
volume of 650 mL consumed by participants. All drinks were well tolerated, consumed 154 
within the allotted time (i.e. 5 min) and resulted in no adverse effects during or after the test 155 
day. Double blinding of the drinks was achieved by having a different researcher from the 156 
individual running the infusion trial prepare the drinks in an opaque bottle ready for 157 
consumption. Despite careful blinding, we cannot discount the possibility that participants 158 
allocated to MYCO may have perceived the unusual texture of mycoprotein. The milk protein 159 
beverage contained 31 g of milk protein powder which contained 26.2 g total protein 160 
(providing 2.5 g of leucine). The mycoprotein beverage contained 70 g of mycoprotein which 161 
contained 31.5 g total protein (providing 2.5 g of leucine). The detailed nutritional content 162 
and amino acid composition of the drinks are displayed in Table 2. 163 
 164 
Blood sample collection and analyses 165 
Ten mL of arterialised venous blood was collected into a syringe at each sampling point. For 166 
each blood sample, six mL was aliquoted into liquid heparin containing tubes (BD vacutainer 167 
LH; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and centrifuged 168 
immediately (3000 g, 4°C, 10 min). Blood plasma was aliquoted and frozen at –80°C for 169 
subsequent analysis. The remaining 4 mL of blood was aliquoted into additional vacutainers 170 
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(BD vacutainers SST II, Becton, Dickinson and Company) which were left to clot at room 171 
temperature for at least 30 min and then centrifuged (3000 g, 4°C, 10 min) to obtain blood 172 
serum. Serum was aliquoted before freezing at –80°C for subsequent analyses. Serum insulin 173 
concentrations were analysed using a commercially available kit (DRG Insulin ELISA, EIA-174 
2935, DRG International Inc, Springfield, IL, USA). Plasma branched chain amino acid 175 
(BCAA) (leucine, isoleucine and valine), phenylalanine and tyrosine concentrations, and L-176 
[ring-2H5]-phenylalanine, L-[ring-3,5-
2H2]-tyrosine, and L-[ring-
2H4]-tyrosine enrichments 177 
were determined by gas chromatography-mass spectrometry (GC-MS) as described 178 
previously (28). Briefly, 10 µL internal standards of leucine, valine, phenylalanine and 179 
tyrosine were added to the samples. The plasma was deproteinised on ice with 500 µL of 180 
15% 5-sulfosalicylic acid. Free amino acids were purified using acid-washed cation exchange 181 
columns (AG 50W-X8 resin; Bio-Rad Laboratories, Inc., CA, USA), with the amino acids 182 
being eluted from the column with 8 mL of 2N ammonium hydroxide. The eluate was then 183 
dried under vacuum with a Speed-Vac rotary dryer (Savant Instruments, Farmingdale, NY, 184 
USA). In order to derivatize the plasma sample, 40 μl MTBSTFA + 1% tert-butyl-185 
dimethylchlorosilane and 40 μl acetonitrile were added to the dry samples, vortexed and 186 
heated at 95 °C for 40 min (29).The samples were analyzed by GC-MS (7890 GC coupled 187 
with a 5975 inert MSD; Agilent Technologies, Santa Clara, CA, USA) in duplicates using 188 
electron impact ionization and selected ion monitoring for measurement of isotope ratios 189 
(30). One microliter of the sample was injected in splitless mode (injector temp. 280°C). 190 
Peaks were resolved using an HP5-MS 30m × 0.25mm ID × 0.25μm capillary column 191 
(Agilent). Helium was used as carrier gas at 1.2ml/min constant flow rate. The temperature 192 
ramp was set from 80 – 245 °C at 11°C/min, then to 280 °C at 40 °C/min (30). Selected ion 193 
recording conditions were used to monitor fragments m/z 336, 341 and 346 for 194 
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phenylalanine, m/z 288 and 296 for valine, m/z 274 and 280 for leucine and isoleucine, and 195 
m/z 466 and 475 for tyrosine.   196 
 197 
Skeletal muscle tissue analyses  198 
Muscle biopsy tissue samples were analysed for protein-bound and free intracellular L-[ring-199 
2H5]phenylalanine, as previously described (28). Briefly, 20-30 mg of frozen muscle tissue 200 
was weighed and precipitated in 600 µL 10% perchloric acid. The tissue was homogenized 201 
by a mechanical tissue grinder. The supernatant, for determination of intracellular L-[ring-202 
2H5]phenylalanine enrichment, was subsequently transferred following centrifugation (4000 203 
rpm, 20 min, 4 °C) and stored at −80 °C. This procedure was repeated with an additional 800 204 
µL wash with 10% perchloric acid. The remaining pellet of muscle tissue was washed three 205 
times in 2% perchloric acid, twice in ethanol, and then once in ethyl ether, before being oven-206 
dried overnight at 50 °C. The following day, the dried muscle pellet was hydrolysed in 6N 207 
hydrochloric acid at 110 °C for 24 h. The hydrolysate, representing the bound protein pool of 208 
amino acids, was subsequently used to determine the enrichment of bound L-[ring-209 
2H5]phenylalanine. The protein hydrolysate was deionized using ion-exchange columns as 210 
described for blood analyses. The supernatant, for determination of intracellular labelled 211 
phenylalanine enrichment, was prepared in the same manner as the protein-bound acid 212 
hydrolysates. In order to derivatize the muscle sample, 50 μl MTBSTFA + 1% tert-butyl-213 
dimethylchlorosilane and 50 μl acetonitrile were added to the dry samples, vortex mixed and 214 
heated at 95 °C for 45 min (29). The samples were analyzed by GC-MS (7890 GC coupled 215 
with a 5975 inert MSD; Agilent Technologies) in duplicates using electron impact ionization 216 
and selected ion monitoring for measurement of isotope ratios (30). One microliter of the 217 
sample was injected in splitless mode (injector temp. 280 °C). Peaks were resolved using an 218 
HP5-MS 30m × 0.25mm ID × 0.25μm capillary column (Agilent). Helium was used as 219 
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carrier gas at 1.2ml/min constant flow rate. The temperature ramp was set from 80 – 245 °C 220 
at 11 °C/min, then to 280 °C at 40 °C/min (30). Selected ion recording conditions were used 221 
to monitor fragments m/z 237 and 239 for the m+3 and m+5 fragments of phenylalanine 222 
bound protein and m/z 336 and 341 for phenylalanine free fraction. 223 
Muscle biopsy tissue samples were analysed for total and phosphorylated forms of 224 
mechanistic target of rapamycin (mTORSer2448 and pmTOR Ser2448). Briefly, ~10 mg of 225 
whole frozen muscle was mechanically homogenised using steel beads (Qiagen, Hilden, 226 
Germany) in 20 volumes of buffer (Tris-HCl 50 mM, Triton X-100 1%, EDTA 1 mM, EGTA 227 
1 mM, NaF 50 mM, β-glycerophosphate 10 mM, sodium pyrophosphate 5 mM, 2-228 
mercaptoethanol 0.1%, sodium orthovanadate 0.5 mM, okadaic acid 100 nM and complete 229 
Mini protease inhibitor cocktail (Roche Holding AG, Basel, Switzerland). Following 230 
centrifugation (10000 g, 4°C, 10 min) the supernatant protein content was determined by 231 
colorimetric assay (DC protein assay, Bio-Rad Laboratories, Inc.). Proteins were unfolded by 232 
incubating for 5 minutes at 95 °C in XT sample buffer (Bio-Rad Laboratories, Inc.). Twenty 233 
µg protein per lane were loaded onto 3-8% tris acetate polyacrylamide gels, and separated by 234 
electrophoresis in XT tricine running buffer for 65 min at 150 V. Proteins were transferred to 235 
0.2 µM nitrocellulose membranes using a Trans-blot turbo transfer system (Bio-Rad 236 
Laboratories, Inc.), at 2.5 A and 25 V for 10 min. Membranes were blocked in 5% BSA in 237 
TBST (pH 7.6) for 1 h, before overnight incubation at 4 °C with rabbit anti-phospho-mTOR 238 
Ser2448 monoclonal antibody (5536, Cell Signaling Technology, Inc., Danvers, Mass, USA; 239 
1:1000 in TBST) and rabbit anti-α-tubulin (11H10, Cell Signaling Technology, Inc.; 1:20000 240 
in TBST) loading control. Following 3 × 10 min washes in TBST, membranes were 241 
incubated for 1 h at room temperature in secondary HRP conjugated anti-rabbit IgG antibody 242 
(ab6721, Abcam PLC, Cambridge, UK; 1:3000 in TBST). Following 3 × 10 min washes in 243 
TBST, membranes were then exposed for 5 min in Clarity Western chemiluminescent 244 
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detector solution (Bio-Rad Laboratories, Inc.), visualised using a Chemidoc scanner (Bio-Rad 245 
Laboratories, Inc.), and band density quantified using Image Lab software (Bio-Rad 246 
Laboratories, Inc.). The expected migration of phospho-mTOR (~289 kDa) and α-tubulin 247 
(~52 kDa) was confirmed using a kaleidoscope protein ladder (Bio-Rad Laboratories, Inc.). 248 
For total mTOR, membranes were incubated for 15 min in Restore stripping buffer (Thermo 249 
Fisher Scientific, Waltham, MA, USA), blocked for 1 h in 5 % BSA in TBST and re-probed 250 
overnight with an anti-mTOR monoclonal primary antibody (2972, Cell Signaling 251 
Technology, Inc.; 1:1000 in TBST) plus anti-α-tubulin, and the above steps were repeated to 252 
obtain corresponding bands for total mTOR. The band density for phospho-mTOR was 253 
calculated as a ratio against the band density for α-tubulin, within each lane. This was divided 254 
by the ratio of mTOR against α-tubulin to give an overall ratio for ‘mTOR phosphorylation 255 
status’, which was finally expressed as a fold change from the rested, fasted, baseline.  256 
Skeletal muscle mRNA expression of 48 genes was analysed as previously described (31). In 257 
brief, total RNA was extracted from ∼20 mg frozen muscle tissue using TRIzolⓇ Reagent 258 
(Thermo Fisher Scientific) (32), according to the manufacturer's protocol. Total RNA 259 
quantification was carried out spectrophotometrically at 260 nm (NanoDrop ND-2000 260 
Spectrophotometer; Thermo Fisher Scientific) and RNA purity was determined as the ratio of 261 
readings at 260/280 nm. Reverse transcription of RNA was carried out using a commercially 262 
available kit (SuperScript™ III First-Strand Synthesis SuperMix, Thermo Fischer Scientific) 263 
(33). Taqman low-density custom-designed array cards (Thermo Fisher Scientific) were used 264 
for the relative quantification of the expression of genes involved in the regulation of cellular 265 
amino acid transport, protein synthesis and protein breakdown. Each card allowed for eight 266 
samples to be run in parallel against 48 Taqman gene expression assay targets that had been 267 
preloaded into each well on the card (Table 4). In short, 50 𝜇L Taqman Universal Master 268 
Mix II (Thermo Fisher Scientific) was added to 150 ng of RNA equivalent cDNA into an 269 
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RNAse-free Eppendorf tube, and RNAse-free water was added to make the total reaction 270 
volume up to 100 𝜇l. The reaction mixture was vortexed, centrifuged and loaded into one of 271 
the fill reservoirs of the Micro Fluidic card, after which the cards were centrifuged (Hereaus 3 272 
S-RMicrofuge, Thermo Fisher Scientific) and run on a 7900HT Fast Real-Time PCR System 273 
(Thermo Fisher Scientific). Relative quantification of the genes of interest was performed 274 
using the delta-delta Ct method, with the fold change in mRNA amplification expressed 275 
relative to the rested fasted leg and the geometric mean of the two housekeeping genes, for 276 
which purpose GAPDH and B2M were selected. 277 
 278 
Calculations 279 
The fractional synthetic rates (FSR) of mixed muscle proteins were calculated using the 280 
standard precursor-product equation (28): 281 
𝐹𝑆𝑅 (% ∙ ℎ-1) = [
∆𝐸p
𝐸precursor × 𝑡
] × 100 282 
Where ΔEp is the increment in L-[ring-2H5]phenylalanine enrichment in mixed muscle 283 
protein between two biopsies, Eprecursor is the average L-[ring-
2H5]phenylalanine enrichment 284 
in the plasma or intracellular precursor pool over time, and t indicates the tracer incorporation 285 
time (h) between two muscle biopsies. 286 
 287 
Intravenous infusion of L-[ring-2H5]-phenylalanine and L-[ring-3,5-
2H2]-tyrosine and 288 
arterialized venous blood sampling were used to assess whole-body amino acid kinetics under 289 
non-steady state conditions (34). Whole-body total phenylalanine rates of appearance (Ra),  290 
rates of disappearance (Rd), and hydroxylation rates (the initial step in phenylalanine 291 



















Fphe + Phe Rd
 295 
Where Fiv is the intravenous tracer infusion rate (μmol∙kg
-1∙min-1), pV (0.125 L∙kg-1) is the 296 
distribution volume for phenylalanine (34), C(t) is the mean plasma phenylalanine 297 
concentration between two consecutive time points, dEiv/dt represents the time-dependent 298 
variations of plasma phenylalanine enrichments derived from the intravenous tracer, and 299 
Eiv(t) is the mean plasma phenylalanine enrichment from the intravenous tracer between two 300 
consecutive time points. Tyr Ra is the total rate of appearance based on the L-[ring-3,5-
2H2]-301 
tyrosine infusion and plasma enrichment of tyrosine. Etyr(t) and Ephe(t) are the mean plasma 302 
L-[ring-2H4]-tyrosine and L-[ring-
2H5]-phenylalanine enrichments between 2 consecutive 303 
time points, respectively, and Fphe is the intravenous infusion rate of L-[ring-
2H5]-304 
phenylalanine (μmol∙kg-1∙min-1).  305 
The absence of an additional (unique) tracer within the protein drinks precluded us being able 306 
to differentiate between endogenous and exogenous Ra. Furthermore, the necessity to enrich 307 
the experimental drinks with the same tracer as was intravenously infused, to minimize 308 
disturbance in precursor isotopic steady states, precluded the calculation of whole body 309 
protein synthesis and breakdown, and provides a degree of error which we presume to be 310 
equivalent across the two groups. 311 
 312 
Statistical analyses 313 
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A two-sided power analysis based on previous research (1) showed that n= 9 per condition was 314 
sufficient to detect expected differences in postprandial muscle protein synthesis rates between 315 
protein conditions (MILK vs MYCO) when using a repeated measures ANOVA (P < 0.05, 316 
90% power, f = 0.67; G*power version 3.1.9.2). Our primary measure was postprandial muscle 317 
protein synthesis rates. The delta change in muscle protein synthesis rates from fasted to fed, 318 
plasma amino acid concentrations (including Cmax and tmax), serum insulin concentrations, 319 
whole body amino acid kinetics, intracellular and mixed muscle protein-bound L-[ring-320 
2H5]phenylalanine represent secondary measures, and skeletal muscle cell signalling responses 321 
represent exploratory variables. Differences in participant characteristics and background 322 
mixed muscle protein-bound L-[ring-2H5]phenylalanine were analysed using independent t-323 
tests. Plasma amino acid and serum insulin concentrations, plasma L-[ring-2H5]-phenylalanine, 324 
L-[ring-3,5-2H2]-tyrosine, and L-[ring-
2H4]-tyrosine enrichments, and muscle mTOR 325 
phosphorylation were tested by two-factor (treatment [milk protein vs mycoprotein] × time) 326 
repeated-measures analysis of variance (ANOVA). Mixed muscle FSRs, mixed muscle 327 
protein-bound L-[ring-2H5]phenylalanine enrichments, and muscle gene expression were 328 
analysed using a three-factor (treatment × time × exercise/rest) ANOVA. Data were tested for 329 
sphericity, and where violations occurred the Greenhouse-Geisser correction was automatically 330 
applied. Violations of normality were tested for using the Shapiro-Wilk test, and no 331 
considerable violations were found. When significant interaction effects were observed Sidak 332 
post hoc tests were performed to correct for multiple comparisons and locate individual 333 
differences. Total postprandial amino acid concentrations were calculated as incremental area 334 
under curve (iAUC), with baseline set as t = 0, and analysed using independent t-tests. 335 
Individual Cmax (peak concentration) and tmax (time to peak concentration) were analysed using 336 
independent t-tests. Where plasma time point data were absent, missing data analyses was 337 
performed using regression imputation. Statistical significance was set at P<0.05. Calculations 338 
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were performed using GraphPad Prism version 7.1 (GraphPad Software, San Diego, CA, 339 
USA). All data are expressed as mean ± SEM.340 





Participant characteristics 344 
No differences in age, weight, height, BMI, body composition, or habitual nutritional intake 345 
were detected between groups (all P>0.05; Table 1). No differences in total work performed 346 
during the experimental resistance exercise bout (29540±1782 J in MILK vs 30722±2059 J in 347 
MYCO; P>0.05) or in fatigue (19±3% in MILK vs 26±4% in MYCO; P>0.05) were detected 348 
between groups. 349 
 350 
Plasma amino acid and serum insulin concentrations  351 
Plasma total and individual BCAA concentrations during the experimental period are shown 352 
in Figure 2. Plasma total BCAA concentrations and each of the individual BCAAs all 353 
showed similar kinetic responses. Specifically, from similar fasting values across conditions, 354 
all parameters increased with protein ingestion (time effect; P<0.0001) but to differing 355 
degrees between conditions (treatment × time interaction effect; P<0.0001). Plasma BCAA 356 
concentrations (A) peaked more rapidly and to a greater peak magnitude following the 357 
ingestion of MILK compared with MYCO. Plasma BCAA Cmax was significantly greater in 358 
MILK compared with MYCO (791±51 vs 646±25.9 μmol·L-1; P<0.05), mean tmax was 359 
82.5±15 min in MILK and 103±10 min in MYCO (P>0.05), and modal tmax was 90 min in 360 
MILK and 120 min in MYCO. Plasma leucine concentrations (C and D) were different 361 
between conditions (treatment effect; P<0.05), and were greater at 15, 30, and 45 min in 362 
MILK compared with MYCO (P<0.01). Plasma leucine concentrations peaked at 30 min in 363 
MILK at 299±36 μmol·L-1 and at 75 min in MYCO at 243±11 μmol·L-1. Plasma leucine Cmax 364 
was significantly greater in MILK compared with MYCO (340±27 vs 258±9 μmol·L-365 
1P<0.01), mean tmax was 80±16 min in MILK and 89±10 min in MYCO (P>0.05), and modal 366 
20 
 
tmax was 30 min in MILK and 75 min in MYCO. Total postprandial plasma leucine 367 
concentrations were 19±8% greater in MILK compared with MYCO (24420±2333 in MILK 368 
vs 20831±1279 μmol·L-1 × 4h in MYCO; P>0.05) (D), whereas isoleucine and valine 369 
postprandial concentrations did not differ between conditions (P>0.05) (F & H). Plasma 370 
phenylalanine and tyrosine concentrations increased with protein ingestion (time effect; 371 
P<0.0001) but also to differing degrees between conditions (treatment × time interaction 372 
effect; P<0.0001). Plasma phenylalanine concentrations (K and L) were greater in MILK 373 
compared with MYCO at 15 and 30 min (P<0.01). Plasma tyrosine concentrations (I and J) 374 
were different between conditions (treatment effect; P<0.001), and were greater in MILK 375 
compared with MYCO from 15-120 min (P<0.05).  376 
Serum insulin concentrations during the experimental period are displayed in Figure 3. From 377 
similar fasting concentrations (15±3 and 16±2 mU·L-1 in MILK and MYCO, respectively) 378 
serum insulin concentrations increased with protein ingestion (time effect; P<0.0001) and to 379 
differing degrees between conditions (treatment × time interaction effect; P<0.0001). Milk 380 
protein ingestion resulted in a more rapid and transient increase in serum insulin 381 
concentrations that peaked at 15 min (42±7 mU·L-1) and returned to fasting levels by 45 min 382 
(P<0.01). Mycoprotein ingestion induced a less rapid but more sustained increase in serum 383 
insulin concentrations that peaked at 30 min post-ingestion (36±4 mU·L-1) and returned to 384 
baseline more slowly (60 min; P<0.0001). Serum insulin concentrations in MILK were only 385 
greater than MYCO at 15 min post-ingestion (P<0.05) and postprandial serum insulin AUC 386 
was not different between conditions (P>0.05). Serum insulin Cmax was not different between 387 
conditions (45±6 vs 38±3 mU·L-1 in MILK and MYCO, respectively; P>0.05), mean tmax was 388 
28±5 min in MILK and 33±4 min in MYCO (P>0.05), and modal tmax was 15 min in MILK 389 




Whole-body phenylalanine kinetics 392 
The time-course of plasma L-[ring-2H5]phenylalanine, L-[3,3-
2H2]tyrosine, and L-[ring-
2H4]-393 
tyrosine enrichments are illustrated in Figure 4. During the postabsorptive period, plasma L-394 
[ring-2H5]phenylalanine remained in a steady state at ~4–5 MPE (mole percent excess) in 395 
both conditions. L-[ring-2H5] phenylalanine enrichments increased transiently after protein 396 
ingestion (time effect; P<0.001), with a greater increase in MYCO (treatment × time 397 
interaction effect, P<0.01). Specifically, plasma L-[ring-2H5]phenylalanine enrichments 398 
increased above postabsorptive levels for 30 min in MYCO only (P<0.01) before returning to 399 
baseline enrichments. This was presumably due to either the slower digestion of MYCO, or 400 
quicker entry of labelled L-[ring-2H5]phenylalanine into the circulation in the MYCO 401 
condition (Figure 4A). Two participants were excluded from the whole body kinetics analysis 402 
(final analysis therefore; MILK=9, MYCO=9) due to technical issues with the tyrosine tracer. 403 
L-[3,3-2H2]tyrosine decreased equivalently after the ingestion of protein (time effect; 404 
P<0.0001, treatment × time interaction effect; P>0.05) and remained below postabsorptive 405 
levels for 150 min following protein ingestion (P<0.05) (Figure 4B). Plasma L-[ring-2H4]-406 
tyrosine increased following protein ingestion (time effect; P<0.0001), with a greater increase 407 
in MYCO (treatment × time interaction effect; P<0.01) which was elevated above 408 
postabsorptive enrichments for 30 min (P<0.0001) (Figure 4C). Phenylalanine hydroxylation 409 
increased following protein ingestion (time effect; P<0.0001), and remained elevated 410 
throughout the postprandial period, with no differences between conditions (treatment × time 411 
effects; P>0.05) (Figure 5A). Plasma phenylalanine total Ra and Rd changed divergently over 412 
time in MILK and MYCO (time and treatment × time effects; P>0.001). In MILK 413 
phenylalanine total Ra and Rd were elevated above postabsorptive values at 90 min (P<0.05), 414 
whereas in MYCO phenylalanine total Ra and Rd were suppressed below postabsorptive 415 




Skeletal muscle tracer analyses 418 
One participants’ samples were excluded from the MYCO condition due to insufficient 419 
tissue. Intracellular L-[ring-2H5]phenylalanine enrichments increased over time (time effect; 420 
P<0.01) with no differences between conditions or interaction effects (both P>0.05) 421 
(Supplementary Figure 2). Mixed muscle protein-bound L-[ring-2H5]phenylalanine 422 
enrichments did not differ between conditions at baseline (0.0030±0.0007 and 0.0034±0.0006 423 
MPE in MYCO and MILK conditions, respectively; P>0.05). Mixed muscle protein L-[ring-424 
2H5]phenylalanine enrichments increased during the fasting period in the rested leg (from 425 
0.0030±0.0007 to 0.0065±0.0007 in MILK and 0.0034±0.0006 to 0.0058±0.0006 MPE in 426 
MYCO; time effect; P<0.0001) to the same extent in each condition (treatment and treatment 427 
× time effects; both P>0.05). Mixed muscle protein L-[ring-2H5]phenylalanine enrichments 428 
increased with protein ingestion (from 0.0065±0.0007 to  0.0161±0.001 MPE in rested, and 429 
0.0061±0.0008 to 0.0164±0.0012 MPE in exercised muscle in MILK, and from 430 
0.0058±0.0006 to 0.0167±0.0012 MPE in rested, and 0.0055±0.0006 to 0.0187±0.0011 MPE 431 
in exercised muscle in MYCO; P<0.0001) and to a greater extent in MYCO compared with 432 
MILK (treatment × time interaction effect; P<0.05) (Supplementary Figure 3).  433 
Mixed muscle FSRs calculated using the average plasma L-[ring-2H5]phenylalanine plasma 434 
enrichment as the precursor pool are displayed in Figure 6. Exercise did not affect mixed 435 
muscle FSR (exercise effect; P=0.0640), nor did exercise interact with protein ingestion 436 
(P=0.1251) or condition (P=0.2223). Protein ingestion increased mixed muscle FSRs in 437 
rested and exercised muscle in both conditions (time effect; P<0.0001). Mixed muscle FSR 438 
increased from 0.036±0.008 to 0.052±0.006%·h-1 and 0.035±0.008 to 0.056±0.005%·h-1 in 439 
rested and exercised muscle, respectively, in MILK, and from 0.025±0.006 to 440 
0.057±0.004%·h-1 and 0.024±0.007 to 0.072±0.005%·h-1 in rested and exercised muscle, 441 
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respectively, in MYCO. The increase in mixed muscle FSR was greater in the MYCO 442 
condition compared with MILK condition (treatment × time interaction effect; P=0.0199), 443 
with the divergence located as trends for a difference between conditions in the 444 
postabsorptive (P=0.0890) and postprandial FSRs (P=0.0930) (A). These trends resulted in 445 
the delta postabsorptive to postprandial rise in mixed muscle FSR being greater in MYCO 446 
compared with MILK (treatment effect; P=0.0084) (B). The group differences became more 447 
pronounced when comparing muscle FSRs derived from the L-[ring-2H5]phenylalanine 448 
intracellular precursor pool. While main effects of exercise or any exercise interactions were 449 
still absent (all P>0.05), protein ingestion increased FSR (time effect; P=0.0003) and to a 450 
greater extent in MYCO compared with MILK (treatment × time interaction effect; 451 
P=0.0225). Specifically, MYCO ingestion stimulated mixed muscle FSR (from to 452 
0.031±0.007 to 0.070±0.006%·h-1 in rested, and 0.028±0.008 to 0.082±0.008%·h-1 in 453 
exercised muscle; P<0.0001), whereas MILK ingestion only trended to stimulate FSR (from 454 
0.040±0.010 to 0.060±0.007%·h-1 in rested, and 0.050±0.012 to 0.058±0.007%·h-1 in 455 
exercised muscle; P=0.060). 456 
 457 
Skeletal muscle cell signalling responses 458 
Skeletal muscle mTOR phosphorylation status was determined in n=15 due to restrictions on 459 
remaining muscle tissue (final analysis therefore; MILK=7, MYCO=8) (Figure 7). Fold 460 
change with protein ingestion in muscle mTOR phosphorylation status did not differ between 461 
conditions (treatment effect; P>0.05), was unaffected by exercise (P>0.05), and did not show 462 
an interaction effect (P>0.05). 463 
Of the 46 genes analysed for their muscle mRNA expression (see Table 4), 19 genes showed 464 
no changes with exercise, protein ingestion, protein condition, or any interactions (all 465 
P>0.05; data not shown). Twenty seven genes responded to protein ingestion and/or exercise, 466 
24 
 
and the muscle mRNA expression of these genes are displayed in Figure 8. Specifically, 467 
protein ingestion either decreased (IRS1, TSC1, TSC2, CASTOR1, FOXO3, CAPN1, SRF, 468 
SLC7A8, SLC38A10, DDIT4, TRIM63 and SLC38A2) or increased (AKT1S1 and 469 
SLC38A9) muscle mRNA expression of some genes. Similarly, exercise decreased (SMAD2, 470 
PIK3R1, RPS6KB1, TFEB, MSTN, SLC38A2 and TRIM32) or increased (FBXO32, 471 
SLC7A1, and TRIM63) the muscle mRNA expression of some genes. Fifteen genes exhibited 472 
a time × exercise interaction (P<0.05) such that EIF4E and TGFb1 mRNA expression 473 
increased in exercised muscle only, and DDIT4L and MSTN mRNA expression increased in 474 
rested muscle only (P<0.05). FBXO32, MSTN, TRIM63 mRNA expression decreased in 475 
rested muscle only, and SLC38A10, DDIT4, SLC38A2, and TRIM32 mRNA expression 476 
decreased in exercised muscle only (P<0.05). Only a single gene, TRIM32, showed a 477 
differential response between nutritional conditions, with its muscle mRNA expression 478 
greater in MILK compared with MYCO (treatment effect; P<0.05), which was driven by a 479 




We assessed in vivo protein synthetic responses to the ingestion of leucine matched boluses 482 
of milk protein and mycoprotein within resting and exercised skeletal muscle, in healthy and 483 
trained, young men. In support of our initial hypothesis, mycoprotein ingestion robustly 484 
stimulated protein synthesis rates in resting and exercised muscle. Mycoprotein ingestion 485 
resulted in slower and lower rises in plasma amino acid (and leucine) concentrations 486 
compared with the ingestion of milk protein. Despite this, and contrary to our secondary 487 
hypothesis, we report that mycoprotein ingestion stimulated muscle protein synthesis rates to 488 
a greater extent when compared with milk protein.  489 
Previous work has suggested that the rate and/or magnitude of plasma essential 490 
aminoacidemia and leucinemia following dietary protein ingestion are the key determinants 491 
that modulate postprandial muscle protein synthesis rates (2, 6, 24, 35-37). As expected (23), 492 
we observed more rapid protein digestion and intestinal amino acid absorption rates 493 
following milk compared with mycoprotein ingestion, as evidenced by larger and more rapid 494 
postprandial aminoacidemia and leucinemia (Figures 2A-D). As a consequence, milk protein 495 
ingestion resulted in a quicker rise in circulating insulin concentrations (Figure 3A), also a 496 
postprandial systemic condition expected to facilitate muscle protein anabolism (38). In line 497 
with our hypothesis, we observed a robust stimulation of mixed muscle protein synthesis 498 
rates in response to both protein sources (Figure 6A). However, we report a greater 499 
stimulation of mixed muscle protein synthesis rates following mycoprotein compared with 500 
milk protein ingestion (Figure 6A). Moreover, when expressing these data as the change in 501 
muscle protein synthesis rates from postabsorptive to postprandial (Figure 6B), the response 502 
to mycoprotein ingestion was more than double that of milk protein ingestion. Given this 503 
response occurred despite ‘inferior’ postprandial plasma amino acid kinetics, it is of interest 504 
to consider why this was observed.  505 
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In studies where isolated protein sources are ingested (i.e. with little or no additional 506 
macronutrients), the rate and/or magnitude of leucinemia generally predicts subsequent rates 507 
of muscle protein synthesis (2, 24, 35, 36). However, in studies where protein was co-508 
ingested with carbohydrate or fat, plasma leucine concentrations were less predictive of the 509 
subsequent muscle protein synthetic response. For example, carbohydrate co-ingestion can 510 
markedly attenuate the peak (and total) magnitude of postprandial leucinemia, but does not 511 
inhibit the muscle protein synthetic response compared with protein ingestion alone (39-42). 512 
This suggests, within the context of a mixed meal, plasma leucine kinetics alone do not 513 
dictate the postprandial muscle protein synthetic response. Further, co-ingestion of additional 514 
macronutrients per se do not confer additional stimulation of muscle protein synthesis rates 515 
(39-42), and therefore neither the additional macronutrients nor energy content of the 516 
mycoprotein can (solely) explain its greater anabolic response in the present study. In line 517 
with our findings, a recent study reported that protein consumed within a ‘whole food’ matrix 518 
(i.e. whole eggs) led to a delayed and lower peak magnitude of postprandial leucinemia, but 519 
greater rates of postprandial muscle protein synthesis compared with the protein ingested 520 
within the egg white only (21). It is therefore possible that the present data, and those from 521 
van Vliet and colleagues (21), are a result of a potentiating effect of consuming protein within 522 
a more complete food matrix/whole food meal. Whether this is an effect of the food matrix 523 
per se (42), a combined effect of the presence of additional macronutrients (or their specific 524 
subclasses (43-45)), fibre (mycoprotein is high in fibre composed of a 2:1 ratio of β-glucan 525 
and chitin), higher energy content, or an effect of other (micronutrient) factors (46-48) is 526 
unclear but clearly warrants future investigation.  527 
To investigate how mycoprotein enabled such a potent muscle protein synthetic response, we 528 
used the remaining muscle tissue to probe various myocellular signalling responses (Figure 7 529 
and 8). Aside from amino acids, it has been suggested that systemic rises in non-protein 530 
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nutrients (e.g. specific lipids (43, 45)), micronutrients (46)) may also exert influence over 531 
mTOR, the central molecular signalling pathway controlling muscle protein synthesis (49). 532 
Despite the divergent amino acid (and presumably other nutrients) profiles across the two 533 
nutritional conditions we observed no differences between groups in postprandial mTOR 534 
phosphorylation. We cannot discount the possibility that mTOR phosphorylation may have 535 
differed during the early postprandial period (50-52), that the translocation and subcellular 536 
location of mTOR may have differed across conditions (44), that investigating different 537 
phosphorylation sites may have yielded different results (53), that downstream targets of 538 
mTOR may have differed independently, or that our data are not appropriately powered to 539 
detect small, but physiologically relevant differences in phosphorylation status (particularly 540 
given we did not have a complete dataset due to limited tissue availability). Moreover, it is 541 
possible that the translocation and/or subcellular location of mTOR may have differed across 542 
conditions (44). Indeed, recent data suggest the subcellular locality of mTOR is important in 543 
regulating the (postprandial) muscle protein synthetic response (54, 55), and that non-protein 544 
dietary components may influence translocation and the regulation of post-exercise mRNA 545 
translation (44).  546 
To gain insight into the potential adaptive response of the cell we examined the muscle 547 
postprandial and post-exercise transcriptional response. Exercise and protein ingestion 548 
resulted in a coordinated transcriptional response, demonstrated by the mRNA expression of 549 
27 of the 46 genes of interest changing 4 h post protein ingestion with/without exercise. The 550 
upregulation in expression of genes involved in amino acid transport (e.g. CAT1, LAT2, 551 
SNAT2) and protein synthesis (e.g. TSC1, TSC2, DDIT4) underline the rapid transcriptional 552 
responses that occur with nutrition and exercise (10, 56-60) which, at least in part, restore 553 
cellular homeostasis and direct the adaptive response. Additionally, the early inhibition of 554 
myostatin expression with exercise supports the concept that low myostatin expression 555 
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facilitates an anabolic environment (61). Only a single gene, the E3 ubiquitin ligase TRIM32, 556 
differentially responded to the different protein sources; being expressed to a lesser degree 557 
following mycoprotein ingestion. TRIM32 preferentially ubiquitinates actin and desmin 558 
filaments, with reduced levels of TRIM32 reducing the loss of these proteins (62, 63). This 559 
may be indicative of a more potent ability of mycoprotein to suppress excessive post-exercise 560 
muscle protein breakdown, although given the lack of a coordinated response of other 561 
proteolyctic genes (e.g. MAFBx, MuRF1 etc.) this remains conjectural. Clearly, the ability of 562 
prolonged mycoprotein consumption to support resistance training-induced hypertrophy 563 
warrants future investigation. Worthy of note is one caveat of interpreting our cell signalling 564 
data in the present work is the increased risk of making a type 1 error due to due to multiple 565 
testing outcomes. 566 
Two other factors that could have contributed to our findings are worthy of consideration. 567 
First, the mycoprotein drink contained ~20% more protein than the milk protein beverage 568 
(31.5 vs 26.2 g). In young men the muscle protein synthetic response to dietary protein 569 
ingestion plateaus at ~20 g protein (3, 11) (or 0.3 g·kg-1; (26)), which appears to be more due 570 
to leucine content, rather than total protein per se (64), at least when ample protein is 571 
provided (65). We therefore assume, since we fed in excess of 20 g / 0.3 g·kg-1 in both 572 
conditions, that ample protein was available to negate protein amount being a significant 573 
contributing factor. In agreement, systemic amino acid concentrations were lower following 574 
mycoprotein compared with milk protein ingestion, again indicating non-protein/amino acid 575 
factors are likely responsible for the greater muscle protein synthetic effect of mycoprotein. 576 
Second, whilst it is generally assumed that leucine (and the other BCAAs) is the primary 577 
nutritional anabolic trigger (6, 25, 64, 66), it is clear that other essential amino acids (50), 578 
such as arginine (67-69), may also play a role in initiating muscle protein synthesis rates. 579 
Therefore, it is also plausible that the amino acid profile of mycoprotein was simply more 580 
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anabolic than milk protein. This, however, would be contrary to the consensus of in vivo 581 
human data (22), and necessitate that specific amino acids, with a greater preponderance in 582 
the mycoprotein drink, possess anabolic signalling roles that are as yet undocumented in 583 
humans.     584 
To conclude, the bolus consumption of mycoprotein stimulated resting and post-exercise 585 
muscle protein synthesis rates in young men, and to a greater extent than a leucine-matched 586 
bolus of milk protein. These novel data show mycoprotein represents a viable, sustainably 587 
produced non-animal derived alternative dietary protein source to support acute tissue 588 
remodelling in response to exercise.  Our work implies that mycoprotein could be 589 
incorporated into the habitual diet of those undertaking prolonged resistance training to 590 
facilitate muscle hypertrophic responses.591 
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Table 1. Participant characteristics. 
 MILK MYCO 
 (n = 10) (n = 10) 
Age (y) 22 ± 1 22 ± 1 
Body mass (kg) 84 ± 3 81 ± 3 
Height (cm) 178 ± 2 182 ± 3 
BMI (kg·m-2) 26 ± 1 25 ± 1 
Fat (% body mass) 12 ± 2 9 ± 2 
Lean mass (kg) 73 ± 3 73 ± 2 
Total work done (J) 29540 ± 1782 30722 ± 2059 
Energy (MJ·day-1) 9.5 ± 0.8 11.6 ± 0.9 
Protein (g·day-1) 150 ± 20 162 ± 17 
Protein (g·kg-1·day-1) 1.8 ± 0.2 2.1 ± 0.2 
 
Values represent mean ± SEM. MILK, Milk protein ingestion condition; MYCO, mycoprotein 
ingestion condition, BMI, body mass index. Total work represents the amount of work done 
(in J) during the experimental exercise protocol. No statistically significant differences were 




Table 2. The nutritional content of the experimental drinks. 
 
MILK MYCO 
Macronutrients   
Protein (g) 26.2 31.5 
Fat (g) 0.3 9 
Carbohydrate (g) 1.7 7 
Fibre (g) <0.1 17.5 
Energy (kcal) 108 238 
Energy (kJ) 458 996 
Amino acid content (g) 
  
Alanine 0.8 2.0 
Arginine 0.9 2.2 
Aspartic acid 1.9 3.3 
Glutamic acid 5.8 3.9 
Glycine 0.5 1.5 
Histidine 0.8 0.8 
Isoleucine 1.3 1.5 
Leucine 2.5 2.5 
Lysine 2.1 2.6 
Phenylalanine 1.3 1.5 
Proline 2.7 1.6 
Serine 1.5 1.6 
Threonine 1.1 1.7 
Tryptophan - 1.2 
Tyrosine 1.3 1.2 
Valine 1.7 1.9 
 
 
Protein content (g) is calculated from the sum of amino acids measured after protein 
hydrolysis. The experimental drinks contained 31 g and 70 g of total product for MILK and 





Table 3. Muscle protein synthesis rates (FSR) before and after protein ingestion, and 
resistance exercise. 
  Postabsorptive Postprandial 
MILK Rested 0.036 ± 0.008 0.052 ± 0.006 
(n = 10) Exercised 0.035 ± 0.008 0.056 ± 0.005 
MYCO Rested 0.025 ± 0.006 0.057 ± 0.004 
(n = 9) Exercised 0.024 ± 0.007 0.072 ± 0.005 
 
Values represent mean ± SEM. Mixed muscle protein fractional synthesis rates (FSRs; A) 
calculated from the plasma L-[ring-2H5]phenylalanine precursor pool in the postabsorptive 
(fasted) and postprandial (fed) state, in rested and exercised (single bout of unilateral 
concentric leg extensions) muscle in healthy young men. Postprandial state represents a 4 h 
period following the ingestion of 26.2g milk protein (MILK; n=10) or 31.5g mycoprotein 
(MYCO; n=9). Data were analysed with three-way ANOVA. Time effect, P<0.0001; 
treatment effect, P=0.99; exercise effect, P=0.06; treatment × time, P=0.02; treatment × 




Table 4. Names and symbols of gene expression assay targets that were preloaded on to the 
microfluidic cards. 
Gene name (human skeletal muscle) Symbol 
Insulin Receptor substrate 1 IRS1 
AKT serine/threonine kinase 1 AKT1 
AKT serine/threonine kinase 2 AKT2 
phosphoinositide-3-kinase regulatory subunit 1 PIK3R1 
mechanistic target of rapamycin MTOR 
ribosomal protein S6 kinase B1 RPS6KB1 
eukaryotic translation initiation factor 4E binding protein 1 EIF4EBP1 
eukaryotic translation initiation factor 4 gamma 1 EIF4G1 
eukaryotic translation initiation factor 4E EIF4E 
sestrin 2 SESN2 
GATS protein like 3 GATSL3 
leucyl-tRNA synthetase LARS 
MAP kinase interacting serine/threonine kinase 2 MKNK2 
transcription factor EB TFEB 
tuberous sclerosis 1 TSC1 
tuberous sclerosis 2 TSC2 
DNA damage inducible transcript 4 DDIT4 
DNA damage inducible transcript 4 like DDIT4L 
regulatory associated protein of MTOR complex 1 RPTOR 
NPR2-like, GATOR1 complex subunit NPRL2 
AKT1 substrate 1 AKT1S1 
forkhead box O1 FOXO1 
forkhead box O3 FOXO3 
forkhead box O4 FOXO4 
calpain 1 CAPN1 
calpain 3 CAPN3 
caspase 3 CASP3 
 
 
nuclear factor kappa B subunit 1 NFKB1 
F-box protein 32 FBXO32 
tripartite motif containing 63 TRIM63/MuRF1 
tripartite motif containing 32 TRIM32 
activating transcription factor 4 ATF4 
Myostatin MSTN 
growth differentiation factor 11 GDF11 
SMAD family member 2 SMAD2 
SMAD family member 3 SMAD3 
transforming growth factor beta 1 TGFB1 
inhibin beta A subunit INHBA 
solute carrier family 7 member 5 SLC7A5 
solute carrier family 7 member 8 SLC7A8/LAT2 
solute carrier family 36 member 1 SLC36A1 
solute carrier family 7 member 1 SLC7A1 
solute carrier family 38 member 2 SLC38A2 
solute carrier family 38 member 9 SLC38A9/SNAT9 
solute carrier family 38 member 10 SLC38A10 
serum response factor SRF 









Figure 1. Schematic representation of the experimental protocol. 
 
Figure 2. The timecourse and incremental AUC (iAUC) of plasma total branched chain amino 
acid (A and B), leucine (C and D), isoleucine (E and F), valine (G and H), tyrosine (I and J) 
and phenylalanine (K and L) concentrations during a 3 h postabsorptive period (time-course 
graphs only) and a 4 h postprandial period in healthy young men. iAUC graphs represent total 
4 h postprandial plasma concentrations above postabsorptive values. The vertical line on each 
graph indicates the transition from postabsorptive to postprandial conditions via the ingestion 
of 26.2g milk protein (MILK; n=10) or 31.5g mycoprotein (MYCO; n=10), where a single bout 
of unilateral leg extension exercise was also performed. Time-course and iAUC data were 
analysed with a repeated measures two-way ANOVA and independent t-tests, respectively, 
with Sidak’s post hoc tests applied to locate individual differences (P≤0.05). Values are means, 
with their standard errors represented by vertical bars. * indicates individual differences 
between conditions at these time points, and a difference between conditions on the bar graphs. 
Treatment × time interaction effect; all P<0.0001. 
 
Figure 3. The timecourse and incremental AUC (iAUC) of serum insulin concentrations during 
a 3 h postabsorptive period (time-course graph only) and a 4 h postprandial period in healthy 
young men, with iAUCs representing total 4 h postprandial plasma concentrations above 
postabsorptive values. The vertical line on each graph indicates the transition from 
postabsorptive to postprandial conditions via the ingestion of 26.2g milk protein (MILK; n=10) 
or 31.5g mycoprotein (MYCO; n=10), where a single bout of unilateral leg extension exercise 
was also performed.  Data were analysed with a repeated measures two-way ANOVA and 
 
 
independent t-tests, respectively, with Sidak’s post hoc tests applied to locate individual 
differences (P≤0.05). Values are means, with their standard errors represented by vertical bars. 
* indicates individual differences between conditions at these time points, and a difference 
between conditions on the bar graph.  Treatment × time interaction effect; P<0.0001.  
 
Figure 4. L-[ring-2H5]phenylalanine (A), L-[3,3-
2H2]tyrosine (B), and L-[ring-
2H4]-tyrosine 
(C) enrichments during a stable isotope experimental test day in healthy young men. The 
vertical line on each graph indicates the transition from postabsorptive to postprandial 
conditions via the ingestion of 26.2g milk protein (MILK; n=10) or 31.5g mycoprotein 
(MYCO; n=10), where a single bout of unilateral leg extension exercise was also performed. 
Data were analysed with a repeated measures two-way ANOVA, with Sidak’s post hoc tests 
applied to locate individual differences (P≤0.05). Values are means, with their standard errors 
represented by vertical bars. * indicates different from fasting (t = 0 min) for MYCO. 
Horizontal bar indicates a change from t=0 across conditions. Treatment × time interaction 
effect; A, P=0.0018; B, P=0.5357; C, P=0.0026. 
 
Figure 5. Total phenylalanine rate of appearance (Ra; A), total phenylalanine rate of 
disappearance (Rd; B), and phenylalanine hydroxylation (C) during a 3 h postabsorptive period 
and a 4 h postprandial period in healthy young men. The vertical line on each graph indicates 
the transition from postabsorptive to postprandial conditions via the ingestion of 26.2g milk 
protein (MILK; n=9) or 31.5g mycoprotein (MYCO; n=9), where a single bout of unilateral 
leg extension exercise was also performed. Data were analysed with a repeated measures two-
way ANOVA, with Sidak’s post hoc tests applied to locate individual differences (P≤0.05). 
Values are means, with their standard errors represented by vertical bars. Treatment × time 




Figure 6. Mixed muscle protein fractional synthesis rates (FSRs; A) calculated from the plasma 
L-[ring-2H5]phenylalanine precursor pool in the postabsorptive (fasted) and postprandial (fed) 
state, in rested and exercised (single bout of unilateral concentric leg extensions) muscle in 
healthy young men. Postprandial state represents a 4 h period following the ingestion of 26.2g 
milk protein (MILK; n=10) or 31.5g mycoprotein (MYCO; n=9). Data were analysed with 
three-way ANOVA, with Sidak post hoc tests applied to locate individual differences. The 
delta change in FSR in response to protein ingestion (B), representing the transition from 
postabsorptive to postprandial conditions in both groups is also presented. Data were analysed 
with two-way ANOVA, with Sidak’s post hoc tests applied to locate individual differences 
(P≤0.05). Values are means, with their standard errors represented by vertical bars. † indicates 
a main effect of protein ingestion. There was a trend for a difference in postprandial muscle 
protein synthesis rates between protein conditions (P=0.093). # represents a main effect of 
condition. 
 
Figure 7. Skeletal muscle mechanistic target of rapamycin (mTOR) phosphorylation status, 
presented as a ratio of phosphorylated (p) to total protein, in the postabsorptive and postprandial 
state, in rested and exercised legs, after the ingestion of 26.2g milk protein (MILK; n=7) or 
31.5g mycoprotein (MYCO; n=8), in young men. Values are means, with their standard errors 
represented by vertical bars. Data were analysed with two-way ANOVA. No significant effects 
were detected. 
 
Figure 8. Skeletal muscle mRNA expression of genes involved in muscle protein synthesis, 
muscle protein breakdown, and amino acid transport in the postabsorptive and postprandial 
state, in rested and exercised legs, after the ingestion of 26.2g milk protein (MILK; n=10) or 
 
 
31.5g mycoprotein (MYCO; n=10), in young men. Data were analysed using three-way 
ANOVA, with Sidak’s post hoc tests used to detect differences (P≤0.05). Values are means, 
with their standard errors represented by vertical bars. There was a main effect of protein 
ingestion for IRS1, TSC1, TSC2, GATSL3, AKT1S1, CAPN1, FOXO3, SRF, LAT2, SNAT9, 
SLC38A10, DDIT4, TRIM63, and SLC38A2 (P<0.05). There was a time × exercise interaction 
effect for MSTN, DDIT4L, FBXO32, TRIM63, SLC38A10, DDIT4, SLC38A2, TRIM32, 
EIF4E, LARS, TGFB1, TFEB, PIK3R1, RPS6KB1, and SLC7A1 (P<0.05). SMAD2 showed 
a main effect of exercise (P<0.05). RPTOR and TSC1 showed a three way interaction (time × 
condition × exercise; P<0.05). 
